Crossmark

The Analgesic Effects of Baclofen 5% Topical Cream for Treatment of Diabetic Peripheral Neuropathy: a Placebo-Control and Double-Blinded Clinical Trial

Crossref DOI link: https://doi.org/10.1007/s42399-021-01108-7

Published Online: 2022-03-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ala, Shahram

Enayatifard, Reza

Monajati, Mahila

Koulaeinejad, Neda

Lashkardoost, Hossein

Mousavi-Kani, Seyedeh Sahar

Rasouli, Shahin

Sahebnasagh, Adeleh https://orcid.org/0000-0001-9361-1641
License Information

Text and Data Mining valid from 2022-03-29

Version of Record valid from 2022-03-29
More Information

Article History

Accepted: 21 December 2021

First Online: 29 March 2022

Declarations

:

: The ethical committee of Mazandaran University of Medical Sciences approved the study protocol (Ethics Code; IR.Mazums.Rec.95–2371). All patients received verbal and printed information, and all provided written consent before entry into this study.

: All patients received verbal and printed information, and all provided written consent before entry into this study.

: Consent for publication was agreed upon in the written consent forms signed by the patients.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below